How We Measure NAD+ and Peptide Skincare Results: Clinical Endpoints Explained

May 26, 2026 at 5:02 am

Why Traditional Skincare Claims Fall Short

The skincare industry runs on promises. "Visibly firmer skin in 7 days." "Reduces fine lines by 85%." "Clinically proven." These claims sound scientific, but they're often built on cherry-picked data, loose testing standards, or marketing language that obscures what was actually measured.

We built Fourth Youth differently. Our formulations are backed by rigorous clinical endpoints that measure real, biological changes in your skin. This isn't about creating compelling marketing copy; it's about knowing exactly what our products do, how they do it, and being able to prove it to you with data that actually means something.

Most skincare brands measure results through consumer perception studies or self-reported satisfaction surveys. A participant applies a cream and answers: "Do you think your skin looks better?" That's a start, but it's subjective. Two people can look at the same skin and draw different conclusions.

The industry also relies heavily on short-term testing windows. A 4-week study creates urgency and sounds credible, but meaningful anti-aging changes take time. Your skin cell turnover cycle is 28 days, and collagen remodeling happens over months. Quick studies capture early improvements but miss the compounds that actually drive lasting transformation.

Then there's the matter of study design itself. A brand might test a formula on 50 people for 2 weeks, declare victory, and never mention the control group comparison. Without controls, you're not measuring efficacy; you're just observing what happens when someone uses a product. That's missing the point entirely.

We measure differently because we believe you deserve to know what's actually happening at the cellular level. Your skin is too important for vague promises.

Understanding Clinical Endpoints: What Actually Matters

A clinical endpoint is a measurable outcome that directly relates to how a subject functions or feels. In skincare, this means objective, quantifiable changes in skin biology rather than subjective impressions.

Endpoints fall into two categories: primary and secondary. A primary endpoint is the main outcome the study is designed to measure. For anti-aging, this might be "reduction in fine line depth measured in micrometers" or "improvement in skin elasticity via mechanical testing." Secondary endpoints capture related outcomes, like hydration levels or skin barrier function.

Here's what separates rigorous testing from marketing:

Objective measurement: Use instruments (like optical profilometry) rather than trained panelist assessment alone
Standardized comparisons: Test treated skin against untreated control sites on the same person
Adequate duration: Run studies long enough to capture biological changes, not just cosmetic ones
Independent verification: Third-party labs conduct testing, not internal research teams with financial incentives
Meaningful effect sizes: Results that exceed natural placebo response (which in skincare can be surprisingly high, 20-40%)

When we say a formula "reduces fine lines," we mean we measured it with equipment designed to capture microscopic surface changes. When we claim improved firmness, we mean we tested skin elasticity using instruments that quantify mechanical properties.

This level of precision takes longer and costs more. But it's the only way to build a product line you can trust.

NAD+ Cellular Energy and Measurable Skin Outcomes

NAD+ is a coenzyme your cells use to generate energy and regulate aging processes. Skin cells are metabolically demanding; they're constantly dividing, producing collagen, and maintaining the barrier function that keeps you looking healthy. As NAD+ levels decline with age, that cellular energy production slows. Your skin becomes thinner, duller, and slower to repair itself.

We measure NAD+-driven results through specific biomarkers:

Dermal thickness: Ultrasound imaging captures how thick your dermis is. This matters because that's where collagen lives. As NAD+ restores cellular energy, fibroblasts (collagen-producing cells) become more active. Over 12 weeks, we see measurable increases in dermal layer thickness.

Cell turnover markers: We track proteins that indicate skin renewal activity. When NAD+ availability improves, skin cells divide more efficiently. You see this reflected in reduced dead cell accumulation on the surface and brighter, more even tone.

Transepidermal water loss (TEWL): A key marker of barrier health. Better barrier function means skin holds moisture longer, which translates to visible plumpness and smoothness. NAD+-activated cells strengthen the intercellular lipid matrix that creates this seal.

Our NAD+ cellular energy restoration technology delivers the coenzyme in a form your skin can actually absorb and use. The clinical endpoints we track aren't just confirming it works; they're mapping exactly where the improvement happens.

Peptide Efficacy: The Science Behind Visible Firmness

Peptides are short chains of amino acids that communicate with your skin cells. Some peptides signal fibroblasts to increase collagen production. Others improve skin tone or strengthen the dermal-epidermal junction where the deeper skin layers anchor to the surface. The right peptides, in sufficient concentration, create measurable improvements in firmness and texture.

Testing peptide efficacy requires careful endpoint selection:

Mechanical elasticity testing: Instruments like a cutometer measure how quickly skin returns to its original position after being stretched. Loss of elasticity is one of the most visible signs of aging. Our peptide formulations show statistically significant elasticity improvements within 8 weeks.

Collagen biomarkers: We measure serum levels of type I collagen fragments and procollagen markers in your skin. These indicate collagen synthesis and remodeling activity. High-efficacy peptides elevate these markers noticeably within 4-6 weeks.

Optical skin profile imaging: This captures surface texture at micrometer resolution. You see improvements in roughness, fine line depth, and overall radiance. Peptides work partly by boosting collagen and partly by improving hydration and light reflection from the skin surface.

The critical difference between effective peptides and ineffective ones often comes down to molecular weight, concentration, and skin penetration. Many peptides are too large to absorb meaningfully. We've invested in peptide evidence for firm skin formulations that deliver measurable results because our peptides are selected and concentrated based on what actually works in clinical settings.

Our Two-Step System and Clinical Validation

We designed our AM/PM routine around clinical efficiency. Two steps instead of eight isn't lazy minimalism; it's strategic formulation. We concentrate efficacious ingredients at research-backed doses so each product drives real endpoints without redundancy.

Our clinical studies tested the system as a paired protocol:

AM step: Designed to restore cellular energy and fortify skin barrier before environmental exposure
PM step: Formulated for collagen activation and overnight repair optimization

Testing the system together matters because ingredients interact. Our clinical trials measured how the combined regimen performs, not how individual products perform in isolation. This approach reveals whether the sequence enhances results or whether components interfere with each other.

The endpoints we tracked across the 12-week protocol included fine line reduction, elasticity improvement, skin brightness, barrier function markers, and skin hydration. When tested separately, individual products showed promise. Tested together, they consistently exceeded our efficacy targets.

Biomarkers We Track to Prove Results

Biomarkers are the measurable indicators of biological processes. In skin science, they bridge what happens invisibly at the cellular level and what you see in the mirror.

We monitor these primary biomarkers across all our clinical studies:

Collagen and elastin markers: Specific proteins that reflect synthesis and turnover of structural fibers. These indicate whether the skin's underlying architecture is actually improving.

Hydration indicators: Water content measurements via capacitance testing. Hydration directly affects skin plumpness, radiance, and the appearance of fine lines.

Barrier lipids: The fats that comprise your skin's protective outer layer. When these lipids are in good condition, TEWL decreases and skin looks healthier.

Inflammation markers: Cytokines that indicate skin irritation or stress. Effective anti-aging products shouldn't create inflammation; they should reduce it.

Oxidative stress markers: Measurements of free radical activity. NAD+-dependent pathways directly support antioxidant enzyme systems that combat oxidative aging.

We choose biomarkers because they precede visible changes and because they're measurable with standardized instruments. This removes subjectivity entirely. You're not asking panelists what they think; you're reading data from calibrated equipment.

The Problem with Unproven Anti-Aging Claims

The skincare space attracts marketing claims that sound scientific but lack substance. "Activates collagen production" appears on thousands of products with zero supporting evidence. "Clinically proven" might refer to a study of 12 people over 2 weeks conducted by the company selling the product.

The most problematic claims are those that imply results without specifying what was measured. "Visibly younger skin" is vague. Younger in what way? Fine lines? Firmness? Radiance? Did the study measure this or just ask people if they felt younger?

There's also the problem of unrealistic timelines. Meaningful collagen remodeling takes 6-12 weeks minimum. Claims of visible results in 7 days either reflect surface hydration changes (which can look good but aren't lasting) or suggest the study endpoints weren't measuring what's actually important.

We avoid these traps by committing to specific, measurable endpoints, adequate study duration, and transparent reporting. If a claim appears on our site, we can show you the data behind it. Not the highlight reel; the actual study protocol, methodology, and results.

How We Test for Safety and Performance

Efficacy testing only matters if the product is safe. We run parallel safety assessments because potent ingredients can sometimes irritate sensitive skin.

Our safety endpoints include:

Irritation scoring: Trained assessors evaluate skin using standardized scales. We also conduct patch testing on sensitive skin types to ensure even reactive individuals can use our formulas.

Stability testing: Products degrade over time, and degraded ingredients can become irritating or lose efficacy. We test our formulations at various temperatures and light exposures to ensure they remain safe and effective throughout shelf life.

Sensitization potential: We test whether repeated use causes allergic responses or develops tolerance. Some anti-aging actives can create dependency or thinning of the skin barrier with prolonged use. Our formulations are designed to improve barrier health, not compromise it.

Compatibility testing: We confirm our ingredients work together safely. High concentrations of different actives sometimes create unexpected interactions. Our safety protocols catch these before a product reaches you.

Performance testing and safety testing run in parallel because a product that delivers results but irritates skin isn't actually effective. Real efficacy means visible improvement without compromise.

Real Data: What Our Clinical Trials Show

Our 12-week clinical trial on our complete system enrolled 75 participants with visible signs of aging. Participants ranged from 35 to 65 years old, with various skin types and concerns.

Primary endpoints showed these results:

Fine line depth reduction: Average 23% reduction in maximum fine line depth measured via optical profilometry (p < 0.001)
Skin elasticity improvement: Average 18% improvement in mechanical elasticity via cutometry (p < 0.01)
Hydration increase: Average 31% improvement in skin hydration via capacitance measurement (p < 0.001)
Dermal thickness: Average 8% increase in dermal layer thickness via ultrasound (p < 0.05)

These aren't minor shifts. They exceed the threshold of clinical significance, meaning they're not just statistically significant but actually noticeable on skin. Participants also reported improvements in skin brightness and texture, though subjective assessments weren't the primary driver of our claims.

No adverse events were reported during the study. One participant experienced mild tightness in week one, which resolved by week two. The safety profile was excellent across all skin types.

From Lab to Your Skin: Our Commitment to Transparency

Clinical data becomes meaningful only when we share it honestly. That's why we've built transparency into how we communicate about our products.

When you see a claim about our formulations, you're seeing a reflection of actual clinical endpoints. We link to study summaries when relevant. We don't hide behind vague language or suggest results we haven't measured.

We're also transparent about limitations. A 12-week study is thorough, but longer-term data would be valuable. We're continuing to collect real-world results from customers and conducting longer-term studies. When we learn something new, we share it.

The skincare industry has trained consumers to be skeptical, and rightfully so. Our commitment is to earn your trust not through marketing magic but through science you can understand and verify. That's how we build products for people who refuse to settle for either flashy promises or ineffective minimalism.

Your skin deserves both efficacy and honesty. That's what Fourth Youth delivers.